Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders for Achieve Life Sciences, Inc. held on June 4, 2025. The company is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol ACHV.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Election of Directors: Seven nominees were elected to the Board of Directors. All nominees received a majority of votes cast "For," with significant broker non-votes recorded for each candidate.
- Ratification of Auditors: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The proposal passed with 26,459,791 votes "For" versus 53,879 "Against."
- Equity Plan Amendment: A proposal to amend the 2023 Non-Employee Director Equity Incentive Plan to increase the number of shares available for issuance was not approved. The proposal received 6,736,105 votes "For" and 7,982,633 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the impact of the failed vote on the 2023 Non-Employee Director Equity Incentive Plan on future director compensation and retention.
- Confirm the composition of the newly elected Board of Directors and their tenure terms.
- Review the company's subsequent filings for any proposed alternative actions regarding the equity plan amendment.